{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:49:59Z","timestamp":1783712999817,"version":"3.55.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1007\/s40264-021-01122-7","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T18:02:46Z","timestamp":1635530566000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Safety of Intravenous Push Levetiracetam Compared to Intravenous Piggyback at a Tertiary Academic Medical Center: A Retrospective Analysis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-8736","authenticated-orcid":false,"given":"Afrah","family":"Alkazemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Schontz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Szumita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"1122_CR1","unstructured":"UCB I. KEPPRA\u00ae (levetiracetam) injection for intravenous use [package insert]. 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021872s005lbl.pdf. Accessed 28 Sept 2021."},{"key":"1122_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","volume":"381","author":"J Kapur","year":"2019","unstructured":"Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019;381:2103\u201313. https:\/\/doi.org\/10.1056\/NEJMoa1905795.","journal-title":"N Engl J Med"},{"key":"1122_CR3","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1177\/0883073808331351","volume":"24","author":"JW Wheless","year":"2009","unstructured":"Wheless JW, Clarke D, Hovinga CA, Ellis M, Durmeier M, McGregor A, et al. Rapid infusion of a loading dose of intravenous levetiracetam with minimal dilution: a safety study. J Child Neurol. 2009;24:946\u201351.","journal-title":"J Child Neurol"},{"key":"1122_CR4","unstructured":"American Society of Health-System Pharmacists. Small-volume parenteral solutions shortages. 2017. https:\/\/www.ashp.org\/Drug-Shortages\/Shortage-Resources\/Publications\/Small-Volume-Parenteral-Solutions-Shortages?loginreturnUrl=SSOCheckOnly. Accessed 28 Sept 2021."},{"key":"1122_CR5","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1528-1167.2006.00586.x","volume":"47","author":"S Ramael","year":"2006","unstructured":"Ramael S, Daoust A, Otoul C, Toublanc N, Troenaru M, Lu Z, et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia. 2006;47:1128\u201335.","journal-title":"Epilepsia"},{"key":"1122_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12028-019-00708-5","volume":"32","author":"O Morgan","year":"2020","unstructured":"Morgan O, Medenwald B. Safety and tolerability of rapid administration undiluted levetiracetam. Neurocrit Care. 2020;32:131\u20134. https:\/\/doi.org\/10.1007\/s12028-019-00708-5.","journal-title":"Neurocrit Care"},{"key":"1122_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345. https:\/\/doi.org\/10.1038\/clpt.1981.154.","journal-title":"Clin Pharmacol Ther"},{"key":"1122_CR8","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O\u2019Neal PV, Keane KA, et al. The Richmond Agitation-Sedation Scale. Am J Respir Crit Care Med. 2002;166:1338\u201344. https:\/\/doi.org\/10.1164\/rccm.2107138.","journal-title":"Am J Respir Crit Care Med"},{"key":"1122_CR9","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1001\/jama.289.22.2983","volume":"289","author":"EW Ely","year":"2003","unstructured":"Ely EW, Truman B, Shintani A, Thomason JWW, Wheeler AP, Gordon S, et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003;289:2983\u201391. https:\/\/doi.org\/10.1001\/jama.289.22.2983.","journal-title":"JAMA"},{"key":"1122_CR10","unstructured":"Baxter International Inc. 3% and 5% sodium chloride injection, USP in VIAFLEX plastic container: prescribing information. 2018. https:\/\/www.baxter.ca\/sites\/g\/files\/ebysai1431\/files\/2018-11\/3pct5pct_NaCl_Inj_EN.pdf. Accessed 28 Sept 2021."},{"key":"1122_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/0885066617702590","volume":"33","author":"RC Dillon","year":"2018","unstructured":"Dillon RC, Merchan C, Altshuler D, Papadopoulos J. Incidence of adverse events during peripheral administration of sodium chloride 3%. J Intensive Care Med. 2018;33:48\u201353. https:\/\/doi.org\/10.1177\/0885066617702590.","journal-title":"J Intensive Care Med"},{"key":"1122_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.4037\/ajcc2017439","volume":"26","author":"GM Jones","year":"2017","unstructured":"Jones GM, Bode L, Riha H, Erdman MJ. Safety of continuous peripheral infusion of 3% sodium chloride solution in neurocritical care patients. Am J Crit Care. 2017;26:37\u201342. https:\/\/doi.org\/10.4037\/ajcc2017439.","journal-title":"Am J Crit Care"},{"key":"1122_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.2146\/ajhp161028","volume":"75","author":"L Meng","year":"2018","unstructured":"Meng L, Nguyen CM, Patel S, Mlynash M, Caulfield AF. Association between continuous peripheral i.v. infusion of 3% sodium chloride injection and phlebitis in adults. Am J Health Syst Pharm. 2018;75:284\u201391.","journal-title":"Am J Health Syst Pharm"},{"key":"1122_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16:48\u201361. https:\/\/doi.org\/10.5698\/1535-7597-16.1.48.","journal-title":"Epilepsy Curr."},{"key":"1122_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/591279","volume":"2015","author":"L K\u00e4mppi","year":"2015","unstructured":"K\u00e4mppi L, Ritvanen J, Mustonen H, Soinila S. Delays and factors related to cessation of generalized convulsive status epilepticus. Epilepsy Res Treat. 2015;2015:1\u201310.","journal-title":"Epilepsy Res Treat."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-021-01122-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-021-01122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T14:09:38Z","timestamp":1642428578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-021-01122-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s40264-021-01122-7","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"21 September 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research required no funding of any type from any agency in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The ICMJE COI form was completed for all authors. Afrah Alkazemi, Kevin C. McLaughlin, Michael G. Chan, Michael J. Schontz, Kevin E. Anger, and Paul M. Szumita declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The retrospective study was approved by Partners Health Institutional Review Board (IRB2018P001700).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable, the article does not contain any studies with human participants or animals performed by any of the authors. For this type of study, formal consent to participate is not required.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable, the article does not contain any studies with human participants or animals performed by any of the authors. For this type of study, formal consent to publish is not required.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The datasets generated during and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AA is responsible for the acquisition of data, analysis and interpretation of data as well as drafting, revising, and final manuscript approval. KCM is responsible for the conceptual design, implementation of the work, interpretation of data, revising, and final manuscript approval. MGC is responsible for the acquisition of data, interpretation of data, drafting, revising, and final manuscript approval. MJS is responsible for the conceptual design of study, implementation of the work, interpretation of data, as well as revising, and final manuscript approval. KEA and PMS are responsible for the conceptual design, revising, and final manuscript approval. All authors read and approved the final version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}